e-learning
resources
Milan 2017
Sunday, 10.09.2017
Classifying COPD with multidimensional scores and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients.
S. Moreira (Lisboa, Portugal)
Source:
International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Session:
Classifying COPD with multidimensional scores and biomarkers
Session type:
Thematic Poster
Number:
1113
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Moreira (Lisboa, Portugal). The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients.. 1113
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations?
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
The 2006 and 2011 GOLD classifications and five-years mortality in COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Differences in the recommended initial therapy of COPD according to GOLD guidelines 2006 and 2011
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
COPD comorbidities and risk assessment according to GOLD 2011 revision
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Usefulness of COPD assessment test (CATÔ) for the management of COPD according to GOLD 2011
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
GOLD 2011 versus GOLD 2017 – What does change?
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
The number of asthma attacks reported by subjects with physician-diagnosed asthma in Italy has increased from 1998-2000 to 2007-2010. Preliminary results
Source: Annual Congress 2012 - Epidemiology of asthma
Year: 2012
The correlation of new GOLD classification (2011 version) with exercise capacity and mortality
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013
Hospitalisations for exacerbations of COPD, France, 1998-2007
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
COPD prevalence in Spain in 2007 (EPI-SCAN study results)
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
Three year follow-up of distribution and stability of patients with COPD according GOLD 2014
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Changes in GOLD Classifications: 2011 versus 2017. Do exacerbations have any role in mortality?
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017
The incidence, prevalence and features of the course of pulmonary sarcoidosis (PS) in Saint-Petersburg for 1998-2006 years
Source: Annual Congress 2007 - Epidemiology of various lung diseases
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept